ZIOPHARM ONCOLOGY INC Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | LEBEL FRANCOIS | Executive Vice Pres ... | Payment of Exercise | F | 5.35 | 21,667 | 115,918 | 137,683 | 159.4 K to 137.7 K (-13.60 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | LEBEL FRANCOIS | Executive Vice Pres ... | Grant | A | 0.00 | 94,350 | 0 | 159,350 | 65 K to 159.4 K (+145.15 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Payment of Exercise | F | 5.35 | 9,333 | 49,932 | 57,967 | 67.3 K to 58 K (-13.87 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Grant | A | 0.00 | 39,300 | 0 | 67,300 | 28 K to 67.3 K (+140.36 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Payment of Exercise | F | 5.35 | 17,292 | 92,512 | 1,209,291 | 1.2 M to 1.2 M (-1.41 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Grant | A | 0.00 | 212,250 | 0 | 1,226,583 | 1 M to 1.2 M (+20.93 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 5.35 | 6,665 | 35,658 | 352,502 | 359.2 K to 352.5 K (-1.86 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 17,204 | 0 | 359,167 | 342 K to 359.2 K (+5.03 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 5.35 | 25,000 | 133,750 | 25,000 | |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Payment of Exercise | F | 5.35 | 10,664 | 57,052 | 140,850 | 151.5 K to 140.9 K (-7.04 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Grant | A | 0.00 | 17,204 | 0 | 151,514 | 134.3 K to 151.5 K (+12.81 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | COO, CLO, and Secre ... | Payment of Exercise | F | 5.35 | 21,667 | 115,918 | 190,217 | 211.9 K to 190.2 K (-10.23 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | COO, CLO, and Secre ... | Grant | A | 0.00 | 94,350 | 0 | 211,884 | 117.5 K to 211.9 K (+80.27 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Payment of Exercise | F | 5.35 | 9,331 | 49,921 | 203,670 | 213 K to 203.7 K (-4.38 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Grant | A | 0.00 | 17,204 | 0 | 213,001 | 195.8 K to 213 K (+8.79 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | BRENNAN MURRAY | Director | Payment of Exercise | F | 5.35 | 10,558 | 56,485 | 53,114 | 63.7 K to 53.1 K (-16.58 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | BRENNAN MURRAY | Director | Grant | A | 0.00 | 17,204 | 0 | 63,672 | 46.5 K to 63.7 K (+37.02 %) |